Europe Bioinformatics Market: Focus on Product and Services, Sector, Application, and Country - Analysis and Forecast, 2025-2035
Description
Introduction to Europe Bioinformatics Market
The Europe bioinformatics market is projected to reach $15.42 billion by 2035 from $4.27 billion in 2024, growing at a CAGR of 12.42% during the forecast period 2025-2035. In Europe, bioinformatics is an interdisciplinary field that combines computer science, biology, chemistry, mathematics, and statistics to evaluate complicated biological data. It is essential for comprehending the composition, operation, and development of biomolecules and systems, supporting research on protein interactions, disease gene identification, and gene expression analysis. Additionally, the field is essential for metabolic pathway research, precision medicine, and drug development. Next-generation sequencing technologies have accelerated the growth of genomic data, which has raised demand for bioinformatics tools in the healthcare and research sectors. AI and machine learning developments are improving data analysis even further, solidifying bioinformatics as a key component of European healthcare, genetics, and life sciences research.
Market Introduction
The market for bioinformatics in Europe is expanding significantly due to the growing need for sophisticated data analysis in systems biology, proteomics, and genomics. Researchers and medical professionals can comprehend molecular structures, gene activities, and protein interactions by using bioinformatics, which combines biology, chemistry, mathematics, statistics, and computer technology to manage and interpret complex biological datasets. Personalized medicine, drug discovery, illness gene identification, and the investigation of metabolic and signaling networks are some of its uses.
The market growth is propelled by the rapid expansion of genomic data, supported by developments in next-generation sequencing (NGS) technologies, high-throughput screening, and molecular diagnostics. The demand for bioinformatics solutions has increased due to the growing adoption of precision medicine programs throughout European nations, which allow for focused therapies and better patient outcomes. In order to improve productivity, shorten the time it takes to discover new drugs, and enable data-driven decision-making, research institutes, pharmaceutical corporations, and biotechnology companies are actively investing in bioinformatics platforms.
Bioinformatics analyses are becoming faster, more accurate, and more scalable thanks to technological advancements like cloud computing, artificial intelligence, and machine learning. The market is also being supported by government programs that encourage genomics research, innovation in the life sciences, and cooperative ventures around Europe. Bioinformatics is still a vital part of Europe's healthcare, genomics, and life sciences research environment, with room to develop and advance technologically despite obstacles such data security issues and the need for qualified experts.
Market Segmentation:
Segmentation 1: By Product and Services
Bioinformatics Software and Tools
Bioinformatics Services
Segmentation 2: By Sector
Medical Biotechnology
Animal Biotechnology
Plant Biotechnology
Forensic Biotechnology
Others
Segmentation 3: By Application
Genomics
Proteomics
Transcriptomics
Metabolomics
Others
Segmentation 4: By Region
Europe
Germany
U.K.
France
Italy
Spain
Rest-of-Europe
Europe Bioinformatics Market Trends, Drivers and Challenges
Market Trends
Increasing integration of AI and machine learning for faster, more accurate data analysis
Growing use of cloud-based bioinformatics platforms for scalable data storage and collaboration
Rising adoption of next-generation sequencing (NGS) and high-throughput technologies in genomics and proteomics research
Expansion of precision medicine and personalized therapy programs across hospitals and research centers
Enhanced application of bioinformatics in drug discovery, molecular diagnostics, and biomarker identification
Growing collaborations between pharmaceutical companies, academic institutions, and technology providers to advance bioinformatics research
Market Drivers
Rapid increase in genomic, proteomic, and metabolomic data requiring sophisticated analysis tools
Rising demand for personalized medicine and targeted therapeutics in Europe
Strong government and EU initiatives promoting life sciences research and genomics projects
Expansion of biotechnology and pharmaceutical R&D activities in key European countries
Technological advancements in AI, machine learning, and data analytics improving bioinformatics capabilities
Need to reduce drug development timelines and enhance research efficiency
Market Challenges
Shortage of skilled bioinformatics professionals to manage and interpret complex datasets
High costs associated with advanced bioinformatics platforms and software
Data privacy and security concerns, particularly with patient genomic information
Integration challenges across diverse datasets and legacy systems
Regulatory compliance complexities for clinical and healthcare bioinformatics applications
How can this report add value to an organization?
Product/Innovation Strategy: The Europe bioinformatics market has been extensively segmented based on various categories, such as product and services, sector, application, and region. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.
Competitive Strategy: The Europe bioinformatics market has numerous established players with product portfolios. Key players in the Europe bioinformatics market, analyzed and profiled in the study, include established players offering products and services for bioinformatics.
Key Market Players and Competition Synopsis
The companies profiled have been selected based on inputs gathered from an analysis of company coverage, product portfolio, and market penetration.
Some prominent names established in this market are:
Eurofins Scientific
Fios Genomics Ltd.
QIAGEN
SOPHiA GENETICS
*PDF email from publisher allows for 1-3 users, with permission to print*
Please Note: It will take 1-5 business days to complete the report upon order confirmation.
The Europe bioinformatics market is projected to reach $15.42 billion by 2035 from $4.27 billion in 2024, growing at a CAGR of 12.42% during the forecast period 2025-2035. In Europe, bioinformatics is an interdisciplinary field that combines computer science, biology, chemistry, mathematics, and statistics to evaluate complicated biological data. It is essential for comprehending the composition, operation, and development of biomolecules and systems, supporting research on protein interactions, disease gene identification, and gene expression analysis. Additionally, the field is essential for metabolic pathway research, precision medicine, and drug development. Next-generation sequencing technologies have accelerated the growth of genomic data, which has raised demand for bioinformatics tools in the healthcare and research sectors. AI and machine learning developments are improving data analysis even further, solidifying bioinformatics as a key component of European healthcare, genetics, and life sciences research.
Market Introduction
The market for bioinformatics in Europe is expanding significantly due to the growing need for sophisticated data analysis in systems biology, proteomics, and genomics. Researchers and medical professionals can comprehend molecular structures, gene activities, and protein interactions by using bioinformatics, which combines biology, chemistry, mathematics, statistics, and computer technology to manage and interpret complex biological datasets. Personalized medicine, drug discovery, illness gene identification, and the investigation of metabolic and signaling networks are some of its uses.
The market growth is propelled by the rapid expansion of genomic data, supported by developments in next-generation sequencing (NGS) technologies, high-throughput screening, and molecular diagnostics. The demand for bioinformatics solutions has increased due to the growing adoption of precision medicine programs throughout European nations, which allow for focused therapies and better patient outcomes. In order to improve productivity, shorten the time it takes to discover new drugs, and enable data-driven decision-making, research institutes, pharmaceutical corporations, and biotechnology companies are actively investing in bioinformatics platforms.
Bioinformatics analyses are becoming faster, more accurate, and more scalable thanks to technological advancements like cloud computing, artificial intelligence, and machine learning. The market is also being supported by government programs that encourage genomics research, innovation in the life sciences, and cooperative ventures around Europe. Bioinformatics is still a vital part of Europe's healthcare, genomics, and life sciences research environment, with room to develop and advance technologically despite obstacles such data security issues and the need for qualified experts.
Market Segmentation:
Segmentation 1: By Product and Services
Bioinformatics Software and Tools
Bioinformatics Services
Segmentation 2: By Sector
Medical Biotechnology
Animal Biotechnology
Plant Biotechnology
Forensic Biotechnology
Others
Segmentation 3: By Application
Genomics
Proteomics
Transcriptomics
Metabolomics
Others
Segmentation 4: By Region
Europe
Germany
U.K.
France
Italy
Spain
Rest-of-Europe
Europe Bioinformatics Market Trends, Drivers and Challenges
Market Trends
Increasing integration of AI and machine learning for faster, more accurate data analysis
Growing use of cloud-based bioinformatics platforms for scalable data storage and collaboration
Rising adoption of next-generation sequencing (NGS) and high-throughput technologies in genomics and proteomics research
Expansion of precision medicine and personalized therapy programs across hospitals and research centers
Enhanced application of bioinformatics in drug discovery, molecular diagnostics, and biomarker identification
Growing collaborations between pharmaceutical companies, academic institutions, and technology providers to advance bioinformatics research
Market Drivers
Rapid increase in genomic, proteomic, and metabolomic data requiring sophisticated analysis tools
Rising demand for personalized medicine and targeted therapeutics in Europe
Strong government and EU initiatives promoting life sciences research and genomics projects
Expansion of biotechnology and pharmaceutical R&D activities in key European countries
Technological advancements in AI, machine learning, and data analytics improving bioinformatics capabilities
Need to reduce drug development timelines and enhance research efficiency
Market Challenges
Shortage of skilled bioinformatics professionals to manage and interpret complex datasets
High costs associated with advanced bioinformatics platforms and software
Data privacy and security concerns, particularly with patient genomic information
Integration challenges across diverse datasets and legacy systems
Regulatory compliance complexities for clinical and healthcare bioinformatics applications
How can this report add value to an organization?
Product/Innovation Strategy: The Europe bioinformatics market has been extensively segmented based on various categories, such as product and services, sector, application, and region. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.
Competitive Strategy: The Europe bioinformatics market has numerous established players with product portfolios. Key players in the Europe bioinformatics market, analyzed and profiled in the study, include established players offering products and services for bioinformatics.
Key Market Players and Competition Synopsis
The companies profiled have been selected based on inputs gathered from an analysis of company coverage, product portfolio, and market penetration.
Some prominent names established in this market are:
Eurofins Scientific
Fios Genomics Ltd.
QIAGEN
SOPHiA GENETICS
*PDF email from publisher allows for 1-3 users, with permission to print*
Please Note: It will take 1-5 business days to complete the report upon order confirmation.
Table of Contents
68 Pages
- Executive Summary
- Scope and Definition
- 1 Europe Bioinformatics Market: Industry Outlook
- 1.1 Market Trends: Current and Future Impact Assessment
- 1.1.1 Strategic Integration of AI and ML in Bioinformatics Solutions
- 1.1.2 Integration of Multi-Omics Data in the Bioinformatics Market
- 1.1.3 Quantum Computing to Transform Bioinformatics
- 1.2 Regulatory Landscape
- 1.3 Pricing Analysis
- 1.4 Market Dynamics
- 1.4.1 Market Drivers
- 1.4.1.1 Rising Private and Public Investments in the Bioinformatics Industry
- 1.4.1.2 Growing Demand for Bioinformatics in Drug Discovery
- 1.4.1.3 Expanding Genomic Data Propelling the Demand for Bioinformatics Tools
- 1.4.2 Market Challenges
- 1.4.2.1 Data Complexity and Heterogeneity Limiting Bioinformatics Growth
- 1.4.2.2 Ethical and Data Privacy Challenges Impacting Bioinformatics Adoption
- 1.4.3 Market Opportunities
- 1.4.3.1 Rising Importance of Metagenomics Offering Growth Potential for Bioinformatics
- 2 Bioinformatics Market, by Region, $Billion, 2023-2035
- 2.1 Europe
- 2.1.1 Regional Overview
- 2.1.2 Driving Factors for Market Growth
- 2.1.3 Factors Challenging the Market
- 2.1.4 Analyst View
- 2.1.5 Market Sizing and Forecast
- 2.1.5.1 Europe Bioinformatics Market (by Product and Services)
- 2.1.5.2 Europe Bioinformatics Market (by Application)
- 2.1.5.3 Europe Bioinformatics Market (by Sector)
- 2.1.5.4 Europe Bioinformatics Market (by Country)
- 2.1.5.4.1 U.K.
- 2.1.5.4.1.1 Country Overview
- 2.1.5.4.1.2 Driving Factors Market Growth
- 2.1.5.4.1.3 Factors Challenging the Market
- 2.1.5.4.1.4 Analyst View
- 2.1.5.4.1.5 Market Sizing and Forecast
- 2.1.5.4.2 Germany
- 2.1.5.4.2.1 Country Overview
- 2.1.5.4.2.2 Driving Factors Market Growth
- 2.1.5.4.2.3 Factors Challenging the Market
- 2.1.5.4.2.4 Analyst View
- 2.1.5.4.2.5 Market Sizing and Forecast
- 2.1.5.4.3 France
- 2.1.5.4.3.1 Country Overview
- 2.1.5.4.3.2 Driving Factors Market Growth
- 2.1.5.4.3.3 Factors Challenging the Market
- 2.1.5.4.3.4 Analyst View
- 2.1.5.4.3.5 Market Sizing and Forecast
- 2.1.5.4.4 Italy
- 2.1.5.4.4.1 Country Overview
- 2.1.5.4.4.2 Driving Factors Market Growth
- 2.1.5.4.4.3 Factors Challenging the Market
- 2.1.5.4.4.4 Analyst View
- 2.1.5.4.4.5 Market Sizing and Forecast
- 2.1.5.4.5 Spain
- 2.1.5.4.5.1 Country Overview
- 2.1.5.4.5.2 Driving Factors Market Growth
- 2.1.5.4.5.3 Factors Challenging the Market
- 2.1.5.4.5.4 Analyst View
- 2.1.5.4.5.5 Market Sizing and Forecast
- 2.1.5.4.6 Rest-of-Europe
- 2.1.5.4.6.1 Regional Overview
- 2.1.5.4.6.2 Driving Factors Market Growth
- 2.1.5.4.6.3 Factors Challenging the Market
- 2.1.5.4.6.4 Analyst View
- 2.1.5.4.6.5 Market Sizing and Forecast
- 3 Competitive Benchmarking and Company Profiles
- 3.1 Company Profiles
- 3.1.1 Eurofins Scientific
- 3.1.1.1 Overview
- 3.1.1.2 Top Products/Product Portfolio
- 3.1.1.3 Top Competitors
- 3.1.1.4 Target Customers
- 3.1.1.5 Key Personnel
- 3.1.1.6 Analyst View
- 3.1.2 Fios Genomics
- 3.1.2.1 Overview
- 3.1.2.2 Top Products/Product Portfolio
- 3.1.2.3 Top Competitors
- 3.1.2.4 Target Customers
- 3.1.2.5 Key Personnel
- 3.1.2.6 Analyst View
- 3.1.3 QIAGEN
- 3.1.3.1 Overview
- 3.1.3.2 Top Products/Product Portfolio
- 3.1.3.3 Top Competitors
- 3.1.3.4 Target Customers
- 3.1.3.5 Key Personnel
- 3.1.3.6 Analyst View
- 3.1.4 SOPHiA GENETICS
- 3.1.4.1 Overview
- 3.1.4.2 Top Products/Product Portfolio
- 3.1.4.3 Top Competitors
- 3.1.4.4 Target Customers
- 3.1.4.5 Key Personnel
- 3.1.4.6 Analyst View
- 4 Research Methodology
- 4.1 Data Sources
- 4.1.1 Primary Data Sources
- 4.1.2 Secondary Data Sources
- 4.1.3 Data Triangulation
- 4.2 Market Estimation and Forecast
- List of Figures
- Figure 1: Europe Bioinformatics Market (by Scenario), $Billion, 2024, 2025, and 2035
- Figure 2: Europe Bioinformatics Market (by Product and Services), $Billion, 2024, 2029, and 2035
- Figure 3: Europe Bioinformatics Market (by Sector), $Billion, 2024, 2029, and 2035
- Figure 4: Europe Bioinformatics Market (by Application), $Billion, 2024, 2029, and 2035
- Figure 5: Bioinformatics Market, $Billion, 2024 and 2035
- Figure 6: Europe Bioinformatics Market, $Billion, 2023-2035
- Figure 7: U.K. Bioinformatics Market, $Billion, 2023-2035
- Figure 8: Germany Bioinformatics Market, $Billion, 2023-2035
- Figure 9: France Bioinformatics Market, $Billion, 2023-2035
- Figure 10: Italy Bioinformatics Market, $Billion, 2023-2035
- Figure 11: Spain Bioinformatics Market, $Billion, 2023-2035
- Figure 12: Rest-of-Europe Bioinformatics Market, $Billion, 2023-2035
- Figure 13: Data Triangulation
- Figure 14: Top-Down and Bottom-Up Approach
- Figure 15: Assumptions and Limitations
- List of Tables
- Table 1: Market Snapshot
- Table 2: Key Market Trends
- Table 3: Bioinformatics Market, Regulatory Landscape
- Table 4: Drivers, Challenges, and Opportunities: Current and Future Impact Assessment
- Table 5: Some of the Public and Private Funding in the Bioinformatics Industry
- Table 6: Bioinformatics Market (by Region), $Billion, 2023-2035
- Table 7: Europe Bioinformatics Market (by Product and Services), $Billion, 2023-2035
- Table 8: Europe Bioinformatics Market (by Application), $Billion, 2023-2035
- Table 9: Europe Bioinformatics Market (by Sector), $Billion, 2023-2035
- Table 10: Europe Bioinformatics Market (by Country), $Billion, 2023-2035
- Table 11: U.K. Bioinformatics Market (by Product and Services), $Billion, 2023-2035
- Table 12: U.K. Bioinformatics Market (by Application), $Billion, 2023-2035
- Table 13: U.K. Bioinformatics Market (by Sector), $Billion, 2023-2035
- Table 14: Germany Bioinformatics Market (by Product and Services), $Billion, 2023-2035
- Table 15: Germany Bioinformatics Market (by Application), $Billion, 2023-2035
- Table 16: Germany Bioinformatics Market (by Sector), $Billion, 2023-2035
- Table 17: France Bioinformatics Market (by Product and Services), $Billion, 2023-2035
- Table 18: France Bioinformatics Market (by Application), $Billion, 2023-2035
- Table 19: France Bioinformatics Market (by Sector), $Billion, 2023-2035
- Table 20: Italy Bioinformatics Market (by Product and Services), $Billion, 2023-2035
- Table 21: Italy Bioinformatics Market (by Application), $Billion, 2023-2035
- Table 22: Italy Bioinformatics Market (by Sector), $Billion, 2023-2035
- Table 23: Spain Bioinformatics Market (by Product and Services), $Billion, 2023-2035
- Table 24: Spain Bioinformatics Market (by Application), $Billion, 2023-2035
- Table 25: Spain Bioinformatics Market (by Sector), $Billion, 2023-2035
- Table 26: Rest-of-Europe Bioinformatics Market (by Product and Services), $Billion, 2023-2035
- Table 27: Rest-of-Europe Bioinformatics Market (by Application), $Billion, 2023-2035
- Table 28: Rest-of-Europe Bioinformatics Market (by Sector), $Billion, 2024-3-2035
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.